
About Aclarion
Aclarion is a publicly listed company based in Broomfield (United States) founded in 2008. SaaS-based radiology image analysis tools are provided for medical providers. Aclarion has raised $3.26 million across 4 funding rounds. The company has 6 employees. Its chief executive, as recorded, is Brent Ness. Aclarion offers products and services including NOCISCAN. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is ACLARION, INC. Its competitors include AIdoc, Lantheus and Vista.ai; 2 of its 3 listed competitors have raised funding.
Company details
Founded in 2008 and based in Broomfield, United States, Aclarion operates in the healthcare technology sector. Software is developed to support radiology image analysis through a SaaS model. Raw medical imaging data is processed into metabolic biomarkers, with features enabled for MRI diagnosis and diagnostic analysis. Assistance is offered to providers for enhanced imaging and diagnostic workflows.
- Headquarters Broomfield, United States
- Employees 6
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website aclarion.com
- Social LinkedIn X
- Legal Name Aclarion, Inc.
- Annual Revenue$75.73 K (USD)65.62as on Dec 31, 2025
- Net Profit-$7.23 M (USD)-3.44as on Dec 31, 2025
- EBITDA-$6.82 M (USD)-28.29as on Dec 31, 2025
- Total Equity Funding$3.26M (USD)
in 4 rounds
- Latest Funding Round$20M (USD), Post-IPO
Feb 2025
- Employee Count6
Products & Services of Aclarion
Aclarion offers a comprehensive portfolio of products and services, including NOCISCAN.
Uses MR Spectroscopy to identify painful spinal discs noninvasively.
Funding Insights of Aclarion
Aclarion has successfully raised a total of $3.26M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $20 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.26M
- Total Rounds 4
- Last Round Post-IPO — $20M
- First Round $3.26M
(May 2018)
All 4 funding rounds of Aclarion with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2025 | $20M | Post-IPO | – | – | – |
| Sep 2024 | $1M | Post-IPO | – | – | – |
| May 2023 | $2M | Post-IPO | – | – | – |
| May 2018 | $3.26M | Series A | – | – | – |
People of Aclarion
4 people are tracked at Aclarion (4 in leadership); the tracked headcount is 6.
| Name | Role | Group |
|---|---|---|
Brent Ness | CEO | Leadership |
Andy Murillo | Director Of Market Access | Leadership |
Ryan D. Bond | Chief Strategy Officer | Leadership |
Leilani Ibarolle | VP Finance | Leadership |
Complete people profiles for Aclarion
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Aclarion
Aclarion is a publicly listed company on the NASDAQ with ticker symbol ACON in USA, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date22 Apr 2022
- Listed onNASDAQ: ACON
- Listed entityAclarion, Inc.
- Exchange sectorTechnology services
- ISINUS6551874091
- Share price$2.14 (-4.68% on the day) · 2026-10-13
- Market capitalisation$6.2M
- EPS (diluted, trailing year)$-7.60
- Volume (last session)21,361
Financials of Aclarion
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $75,730 | -$7.2M | -$6.8M |
| 2024 | $45,720 | -$7.0M | -$5.3M |
| 2023 | $75,400 | -$4.9M | -$4.7M |
| 2022 | $60,440 | -$7.1M | -$5.4M |
| 2021 | $60,290 | -$5.0M | -$2.8M |
Detailed financial statements for Aclarion
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Aclarion
4 dated milestones of Aclarion across 17 years, from founding to its latest funding, stage changes and deals.
- Founded Aclarion is founded.
- Funding First funding round of $3.3M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $20.0M.
Competitors of Aclarion
Aclarion has 3 listed competitors in our database, 2 of them funded. They include AIdoc, Lantheus and Vista.ai.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aidoc.com | 2016 | New York, United States | $424.5M | AI-based single-screen system is provided to streamline medical imaging. | ||
| lantheus.com | 2008 | Billerica, United States | 834 | Developer of diagnostic imaging agents and targeted therapeutics | ||
| vista.ai | 2012 | Palo Alto, United States | $8.7M | 13 | AI-guided software is utilized to automate MRI exams for clinicians. |
Detailed competitors of Aclarion
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Aclarion
The website of Aclarion (aclarion.com) receives about 6.2K visits a month.
- Monthly visits6.2K
▲ 65% vs previous month
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Aclarion (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aclarion
Complete news archive for Aclarion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aclarion
Aclarion was founded in 2008 and raised its 1st funding round 10 years after it was founded.
Aclarion is headquartered in Broomfield, United States. It is registered at Broomfield, Colorado, United States.
Brent Ness is the CEO of Aclarion, as recorded in our data.
Aclarion is a funded company, having raised a total of $3.26M across 4 funding rounds to date. The company's 1st funding round was a Series A of $3.26M, raised on May 2018.
Aclarion has 6 employees.
Annual revenue of Aclarion is $75.73K as on Dec 31, 2025.
Founded in 2008 and based in Broomfield, United States, Aclarion operates in the healthcare technology sector. Software is developed to support radiology image analysis through a SaaS model. Raw medical imaging data is processed into metabolic biomarkers, with features enabled for MRI diagnosis and diagnostic analysis. Assistance is offered to providers for enhanced imaging and diagnostic workflows.
Aclarion offers NOCISCAN.
Yes, Aclarion is publicly traded on NASDAQ under the ticker symbol ACON.
Aclarion operates through Aclarion, Inc..
